11 Stocks in the Limelight After Releasing Their Financial Results

In this article, we will take a look at the 11 stocks in the limelight after releasing their financial results. You can skip our detailed analysis of these companies and go directly to the 5 Stocks in the Limelight After Releasing Their Financial Results.

Stocks from the consumer cyclical and communication services sectors, including The Home Depot, Inc. (NYSE:HD), Global-e Online Ltd. (NASDAQ:GLBE) and Take-Two Interactive Software, Inc. (NASDAQ:TTWO), recently came out with the financial results for their respective quarters.

Shares of Home Depot and Take-Two Interactive rallied in the pre-market trading session on Tuesday, May 17, after beating profit expectations. On the other hand, Global-e Online shares fell to an all-time low after posting a wider-than-expected loss for the first quarter.

In addition, Israel-based tech firms, including monday.com Ltd. (NASDAQ:MNDY) and Wix.com Ltd. (NASDAQ:WIX), also caught investors’ attention following their earnings reports.

Source: PixaBay

Stocks in the Limelight After Releasing Their Financial Results

11. Weber Inc. (NYSE:WEBR)

Number of Hedge Fund Holders: 6

Shares of Weber Inc. (NYSE:WEBR) hit a new 52-week low of $5.72 on Monday, May 16, 2022, after posting disappointing financial results for its fiscal second quarter and a weak outlook for the full year.

Weber Inc. (NYSE:WEBR) reported a loss of $1.02 per share, contrary to analysts’ average estimate for earnings of 18 cents per share. Revenue for the quarter dropped 7 percent on a year-over-year basis to $607.3 million, missing the expectations of $659 million.

For its fiscal year 2022. Weber Inc. (NYSE:WEBR) expects to generate revenue in the range of $1.65 – $1.80 billion, significantly lower than analysts’ average estimate of $2.09 billion.

Commenting on the quarter, CEO Chris Scherzinger said in a statement:

“Our second-quarter results reflect our proactive

Read More

Heliogen, Inc. Announces Full Year 2021 Financial and Operational Results

PASADENA, Calif., March 29, 2022–(BUSINESS WIRE)–Heliogen, Inc. (“Heliogen” or the “Company”) (NYSE: HLGN), a leading provider of AI-enabled concentrated solar energy, today announced full year 2021 financial and operational results.

Full-Year 2021 Highlights

  • Finalized $39 million U.S. Department of Energy award for deployment of AI-enabled concentrated solar technology

  • Completed first field test of autonomous robots designed to reduce installation and maintenance costs

  • Announced start of equipment procurement for first commercial-scale facility collaboration with Woodside Energy to deploy Heliogen’s power technology

  • Held successful demonstration of green hydrogen production using the Company’s core concentrated solar technology in partnership with Bloom Energy

  • Closed business combination with Athena Technology Acquisition Corp. (“Athena”); began trading on the NYSE on December 31, 2021

Recent Highlights

  • Began site preparation and setup for first full-scale manufacturing facility in Long Beach, California

  • Awarded exclusive lease rights to Brenda Solar Energy Zone by the U.S. Bureau of Land Management for the purposes of green hydrogen production

Executive Commentary

“Our mission is bold but simple,” said Bill Gross, Founder and Chief Executive Officer of Heliogen. “We aim to decarbonize heavy industry, using artificial intelligence, scalable, repeatable manufacturing techniques, and the power of the sun. Our patented closed-loop tracking system for our mirrors will allow us to generate temperatures up to 1,000 degrees Celsius, and efficiently store that heat to create industrial process steam, power and green hydrogen – without the intermittency problems of other renewable energy sources.”

Heliogen Progress in 2021 Continues into 2022

During 2021, Heliogen launched negotiations regarding deployment of its AI-enabled solar energy systems, and began engineering work on one of its first commercial scale facilities. The Company also continued to develop its infrastructure and set the foundation for its commercial-scale operations, to support its prospective project pipeline.

“The past year has been

Read More

InnoCare Releases 2021 Annual Results and Business Highlights

BEIJING, March 22, 2022 /PRNewswire/ — InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 annual results as of 31 December 2021.

Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, “We are delighted to announce 2021 results on the occasion of our 2nd anniversary of listing on Hong Kong Stock Exchange. We have witnessed an unusual year 2021, in which we overcame tremendous difficulties and challenges and achieved many significant milestones. We have achieved satisfactory results in the first year of commercialization. The inclusion of orelabrutinib in the National Reimbursement Drug List (NRDL) at the end of 2021 will help access to more patients. We have made major breakthroughs in internationalization by reaching license-out and license-in collaboration with Biogen and Incyte respectively. We have deepened our efforts in innovation and accelerated the progress of our global multicenter clinical trials so as to further advance our drug candidate to benefit more patients…”

Financial Highlights

  • The revenue increased sharply from 1.4 million for the year ended 31 December 2020 to 1.043 billion for the year ended 31 December 2021, due to sales of orelabrutinib and upfront payment from Biogen.

  • The research and development expenses increased from 402.8 million for the year ended 31 December 2020 to 721.6 million for the year ended 31 December 2021, primarily due to the upfront payment of tafasitamab license-in, etc.

  • The cash and cash equivalent increased from 3.9696 billion by the end of 2020 to 6.5505 billion by the end of 2021.

  • The loss for the reporting period decreased from 391.9 million for the year ended 31 December 2020 to 66.7 million for the year ended 31 December 2021, mainly due to the increase of revenue, etc.

(Note: Currency: RMB)

Key

Read More

TPG RE Finance Trust, Inc. Reports Operating Results for the Fourth Quarter and Full Year Ended December 31, 2021

NEW YORK, February 22, 2022–(BUSINESS WIRE)–TPG RE Finance Trust, Inc. (NYSE: TRTX) (“TRTX” or the “Company”) reported its operating results for the fourth quarter and full year ended December 31, 2021.

FOURTH QUARTER 2021 ACTIVITY

  • Generated GAAP net income attributable to common stockholders of $41.4 million, or $0.51 per diluted common share based on a diluted weighted average share count of 82.0 million common shares, and book value per common share on December 31, 2021 of $16.37, an increase of $0.22 over the prior quarter.

  • Declared on December 13, 2021 a cash dividend of $0.24 per share of common stock and a non-recurring special cash dividend of $0.07 per share of common stock. The full cash dividend of $0.31 was paid on January 25, 2022 to common stockholders of record as of December 29, 2021. The Company paid on December 30, 2021, to stockholders of record as of December 20, 2021, a quarterly dividend on the Company’s 6.25% Series C Cumulative Redeemable Preferred Stock (“Series C Preferred Stock”) of $0.3906 per share.

  • Originated 10 first mortgage loans with total loan commitments of $651.6 million, an aggregate initial unpaid principal balance of $564.5 million, a weighted average credit spread of 3.77%, a weighted average interest rate floor of 0.10% and a weighted average loan-to-value ratio of 72.3%.

  • Received loan repayments of $428.1 million, including six full loan repayments totaling $420.9 million.

  • The weighted average risk rating of the Company’s loan portfolio improved to 3.0 as of December 31, 2021, compared to 3.1 in the preceding quarter.

  • Reduced the Company’s CECL reserve at quarter-end by $8.8 million, to $46.2 million or 85 basis points of total loan commitments, down from $55.0 million or 103 basis points as of September 30, 2021.

  • Sold a 17 acre undeveloped land parcel at

Read More

Marqeta Announces Visa Veteran Mike Milotich as New CFO, Raises Expectations for Fourth Quarter 2021 Economical Results

Subsequent 10 years at Visa, Mike Milotich will be a part of Marqeta as Chief Fiscal Officer, overseeing the upcoming chapter of Marqeta’s scale and development

OAKLAND, Calif., February 09, 2022–(Enterprise WIRE)–Marqeta (NASDAQ: MQ), the world wide fashionable card issuing platform, introduced the appointment of Mike Milotich as the company’s new Main Economic Officer, powerful February 22, 2022.

Milotich joins Marqeta adhering to a ten years-extended tenure at Visa in several economical leadership positions, most lately serving as Senior Vice President of Trader Relations and Company Finance. He has additional than 20 decades of encounter in company finance, the bulk of which falls in payments and economical providers. He has also held management positions at American Categorical and PayPal.

Tripp Faix, the company’s outgoing Main Financial Officer, has resolved to phase down to shell out far more time with spouse and children immediately after three and a 50 percent a long time in his role. Mr. Faix will proceed in an advisory position right until March 31, 2022, to make sure a clean transition of the CFO placement at Marqeta and take part in Marqeta’s upcoming meeting call to examine its fourth quarter and whole calendar year fiscal 2021 money final results, set for March 9, 2022.

“Having spent the very last 10 many years at Visa, I had a entrance row seat to the rise of Marqeta and the innovations they’ve opened up globally with their fashionable card issuing system,” explained Mike Milotich. “Right after expending time with Jason and the govt team, I was amazed by both equally how properly they’d scaled to date and the massive chance in world-wide revenue movement that lies in advance of them. I seem ahead to becoming a member of the team and assisting to manual the following

Read More